from the endocrinology & diabetes specialists of the lmc … · 2015. 12. 9. · 2. de vegt f,...
TRANSCRIPT
The ProblemTheType2diabetesmellitus(T2DM)epidemicisgrowingrapidly,withanestimated285millionpeopleworldwidelivingwithT2DMin2010.Almosthalfofthoseaffectedareinthe20-60age-group.Ithasbeenestimatedthatamandiagnosedwithdiabetesattheageof40yearswillloseonaverage11.6life-yearsand18.6qualityadjustedlifeyears(QALY)andwomenwilllose14.3life-yearsand22.0QALYs(1).Thus,primarypreventionofT2DManditscomplicationsisamajorpublichealthissue.
The Opportunity
Impairedfastingglucose(IFG)andImpairedGlucoseTolerance(IGT)areoftenlabeledtogetheras
pre-diabetes(Table1).Thenaturalhistoryandpathophysiologyoftype2diabetesindicatethat
thereexistsaprolongedprediabeticphaseinmostpatients.Ithasbeenestimatedthatthemajority
ofindividuals(upto70%)withprediabeteswilleventuallydevelopT2DM(2).Particularlyhighcon-
versionrates(>10%peryear)havebeenobservedinsubjectswithacombinationof2or3predia-
beticconditions(IGT±IFG±MetabolicSyndrome)(2).Hence,familyphysiciansandspecialistshave
auniqueopportunitytoidentifythesepatientsathighriskfordevelopingdiabetesandintervene.
InadditiontoaveryhighrateofconversiontoT2DM,anincreasedriskofcardiovasculardiseaseis
alreadypresentinprediabeticstates.Consequently,early,preventativeinterventionwillyield
greatbenefit.
C L I N I C A L P R A C T I C E U P D A T E I N
0603
V OLUM E
I S S U E
From the Endocrinology & Diabetes Specialists of the LMC Endocrinolgy Centres. The opinions expressed in this paper are those of the authors and do not necessarily reflect
the opinions of LMC Endocrinology Centres or the editorial board of Clinical Practice Update.
EditorSamantha Sandler
MD, FRCPC
ONTARIOBARRIE
Suzan Abdel-Salam Diane Zatelny
BRAMPTONHarpreet Bajaj
ETOBICOKEHasnain Khandwala
Anila Seth-Sharma
MARKHAMSorin Beca
OAKVILLED. Y. Twum-Barima
THORNHILLJulie Daitchman
Meri GalterRonald Goldenberg
Gloria Rambaldini Robert Schlosser
Nina Wine
TORONTORonnie Aronson
Kimberly Mah-Poy Samantha Sandler
William Singer George Steiner
Adam Telner
QUEBECMONTRÉAL
Nouhad SalibaNahla Aris-Jilwan
MONTRÉALOUEST / WEST
Alex Skamene
ALBERTACALGARY
Munish KhoslaSue Pedersen
Stuart Ross
Dr. Harpreet BajajMD, MPH, ECNUNEPHROLOGIST, HRRHLECTURER, UNIVERSITY OF TORONTO
IMPAIRED FASTING
GLUCOSE (IFG)
IMPAIRED GLUCOSE
TOLERANCE (IGT)or
Shall We Treat?
• Reductionintotalintakeoffatandintake
ofsaturatedfat
• • Increasingintakeofdietaryfiber
• Increasingphysicalactivity
OtheriatrogeniccontributorstoIFG/IGTneed
tobeaddressedaswell.Drugsthatadversely
affectglucosetoleranceshouldbereplacedor
minimized,suchasthiazidediuretics,cortico-
steroidsandatypicalanti-psychotics.
The EvidenceDiabetesPreventionProgram(DPP)—inthis
landmarktrial,3234obesesubjects(average
age51years)athighriskfordiabetes(fasting
and2-hourglucoseconcentrationsbetween5.3
to6.9mmol/Land7.8to11.1mmol/L,respec-
tively)wererandomlyassignedtooneofthe
followinggroups:
• Intensivelifestylechangesthrougha
behavioralmodificationprogram
• TreatmentwithMetformin(850mg
twicedaily)
• Placebo
TheIntensivelifestylegrouplostanaverageof15
pounds(6.8kg;7percent)ofweightinthefirstyear,
mostofwhichwassustainedforthedurationofthe
study.TheintensivelifestyleandMetformininterven-
tionsreducedthecumulativeincidenceofdiabetes
by58and31percent,respectively,comparedwith
placebo(4).
IncontrasttothefindingsintheentireDPPcohort
whichfavoredlifestyleintervention,Metforminand
lifestyleinterventionweresimilarlyeffectiveinreduc-
ingtheincidenceofdiabetesinwomenwithahistory
ofgestationaldiabetes(GDM)(5).Inapreplanned
subsetanalysisofwomenwithahistoryofGDMand
IGT,theincidenceofdiabeteswasreducedby50and
53percentinsubjectsassignedtoMetforminandlife-
styleintervention,respectively,comparedwithpla-
cebo.Thediscrepancyinthetwostudiesisthought
tobedue,inpart,tothehighercumulativeincidence
ofdiabetesinwomenassignedtoplacebowithGDM
versusnoGDM(38.4versus25.7percent)andinpart
duetotheinabilityofwomenwithahistoryofGDM
randomlyassignedtointensivelifestyleintervention
tosustainphysicalactivityandmaintainweightloss.
Inadditiontothishigh-riskGDMsubgroup,Met-
Case: Mrs. Angela AMrs.AngelaAisa42-year-oldadministrativeclerk.
ShehasahistoryofGestationaldiabetes(GDM).She
currentlytakesnomedications.Shehasbeenunable
toloseweightbecauseofherbusyschedule.On
physicalexam,herBMIis28.1andwaistcircumfer-
ence102cm.Bloodpressureis138/84.Hergeneral
physicaliswithinnormallimits,exceptforcentral
obesity.Herfastingglucoseiselevatedat6.4mmol/L.
2hourglucoseaftera75gmOGTTiselevatedto10.1
mmol/L.Twoyearsago,herFBGwas6.1mmol/Lwith
a2-hourvalueof9.2mmol/L.Herfastinglipidpanel
showstotalcholesterol7.03mmol/L,triglycerides4.37
mmol/L,HDL0.90mmol/LandacalculatedLDLof
4.14mmol/L.Basedontheaboveresults,youdiag-
noseMrs.AashavingIFG/IGTinadditiontofeatures
ofmetabolicsyndrome.
The ManagementThereisevidencethatlifestyleintervention(com-
bineddietandexerciseaimedatweightloss)can
improveglucosetoleranceandpreventprogression
fromIFG/IGTtotype2diabetes.Thiswasillustrated
byameta-analysisofeighttrialscomparingexercise
plusdietwithstandardtherapy(RRwithintervention
comparedtocontrol0.63,95%CI0.49-0.79)(3).The
lifestylemodificationadviceisessentiallythesameas
thatindiabetes:
• Weightreduction(5-10%),ifappropriate
(adaptedfromCDAguidelines2008)Note:CDAdoesnotrecommendspecificHbA1Ccriteriafordiagnosisofprediabetes.
Pre-Diabetes
Type 2 DM
ImpairedFastingGlucose
FPG(mmol/L)
2-HourGlucoseAfter75gmOGTT
(mmol/L)
NotAvailable
<7.8
7.8-11.0
7.8-11.0
6.1-6.9
6.1-6.9
6.1-6.9
<6.1
>7.0_ >11.1_
And
And
And
Or
IsolatedIFG
IsolatedImpairedGlucose
Tolerance
BothIFGandIGT
Type2DM
Table 1
Plasma Glucose (PG) levels for diagnosis of IFG, IGT and diabetes
Type 2 DM
forminwasalsofoundtobeparticularlyeffectivein
subjectswhowereyoungerandmoreobese(BMI>35
kg/m2).
The Metformin ArgumentInadditiontopreventionoftype2DMobservedin
DPPandotherpreventionstudies,Metforminhas
beenassociatedwithreductionsinmortality,car-
diovasculardiseaseandcancerincidenceinstudies
involvingtype2DMsubjects.Metforminisarela-
tivelyinexpensivemedicationandhasnoknown
long-termseriousadverseeffects.Gastrointestinal
intoleranceissueswiththisdrugareusuallytransient
andcangenerallybeovercomebyslowtitrationof
Metformindosageoruseofthelonger-actingGlu-
metzaformulation,whichisfrequentlybettertoler-
atedinsomepatients.Aswell,Glumetzamaybe
givenonce-dailyleadingtopotentialimprove-
mentinpatientadherencetothetreatment
regimen.Metforminandlifestyleinterventions
cangohandinhand,asthereisminimalriskof
hypoglycemiawiththecombination.Froman
economicsperspectivetoo,useofMetformin
maysavemoneyovertimewhenusedinprimary
preventionofT2DMby:
• delayorpreventionofT2DMbyreducing
progressionofbetacellfailure,
• betterachievementofglycemiagoals
leadingtolesscomplications,and
• delayorpreventionofMetformin
failureandneedforsecond-lineoral
hypoglycemicagentsinsubjectswhogo
ontodevelopT2DM(6).
Guidelinerecommendationsinmostcountries
(includingCanada)haveincorporatedMetfor-
minasapharmacotherapyoption;thoughmost
recommendlifestyleinterventions,overprescrip-
tionmedications,asthe“therapy”ofchoice
inpreventionoftype2DM.ADArecommends
considerationofMetforminfordiabetes
preventioninhigh-riskindividuals
(Table2).
However,somewouldarguethatpreferenceof
lifestyleoverMetformin(ratherthaninitiationof
bothtogetherfromthebeginning)mayengender
the“denial”phaseinpatientswithpre-diabetes
andearlyT2DM.Practicallyspeaking,therationale
forMetformininpreventionisstrengthenedbytwo
facts:1)onceapatienthasdevelopedIFG/IGT,they
areataveryhighriskforT2DM,2)mostpatientsfind
itdifficulttoinitiateandmaintainweightlosseven
afterrepeatcounseling.Ifintensivelifestyleinterven-
tionischosensolely,overpharmacotherapy,patients
shouldbefollowedannuallywitharepeatOGTT.In
theabsenceofweightlossorwithanyworseningof
IFG/IGT(evenwithinthenon-diabeticrange),addi-
tionofMetforminmaybeindicated.
Back to the case: Mrs. Angela AReviewing,Mrs.AngelaAisayoungwomanwith
ahistoryofGDMandmetabolicsyndrome.Shehas
hadaworseningofherIFG+IGTover2yearsandhas
beenunsuccessfulatweightloss.Hence,basedon
theaboveargumentsandresultsofDPP,Metformin
initiation(eitherastwice-dailyMetforminHydrochlo-
rideorasonce-dailyGlumetza)shouldbestrongly
consideredtoprevent/delayherdevelopmentoftype
2DMandassociatedcomplications.
References:1. Narayan K M, Boyle J P, et al. Lifetime risk for diabetes mellitus in the United States. JAMA 2003; 290: 1884-18902. de Vegt F, Dekker J M, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 2001; 285: 2109-21133. Orozco LJ, Buchleitner AM, et al. Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev 20084. Knowler WC, Barrett-Connor E, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393.5. Ratner RE, Christophi CA, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008; 93:4774.
(adaptedfromAmericanDiabetesAssociationGuidelines2011)
Population Treatment
Table 2
Treatment Recommendation for Individuals with IFG, IGT or both
Lifestylemodification(ie.5to10%weightloss,moderateintensityphysicalactivity–30min/day
Lifestylemodification(asabove)and/orMetforim850mgtwiceperday
IFGorIGT
IFG + IGT + any of the following
<60yearsofage
BMI>35kg/m2
Familyhistoryofdiabetesinfirstdegreerelative
Elevatedtriglycerides
ReducedHDLcholesterol
Hypertension
HbA1c>6.0%
•½cupsteelcutoatmeal•1cupmixedberries•¾cuplowfatyogurt
•¼cupalmonds
•1cupMixedbeansaladwithtomatoes,lemonjuiceandbalsamicvinaigrettedressing•1cupbroccolisalad•1cuplowfatmilk
•1mediumapple
DAY 1 DAY 2
•2piecesofsourdough/stonegroundwholegrainbread•1-2Tbsppeanutbutter•1cuplowfatmilk
•3/4cuplowfatyogurt
•Tunapastasalad•1cuppasta,cookedeldente•2cupsmixedvegetables•1/2cuptuna•Lightmayonnaise•Lemonjuice•1cuplowfatmilk
•3/4cuplowfatyogurt
breakfast
snack
lunch
snack
dinner•2/3cupbasmatiorDoongararice•4-5ounceporkchop•Mushroomsaladwithbalsamicvinaigrette•Mixedgreensaladwithlowfatdressing•1cupfruitsalad
•4-5ouncechickenbreast•3/4cupQuinoasalad•Largespinachsaladwithraspberryvinaigrettedressing•1cuplowfatmilk
Supported by educational grants from members of the pharmaceutical industry.
TORONTO• OAKVILLE • ETOBICOKE • THORNHILL • BARRIE • MARKHAM• BRAMPTON• MONTREAL • CALGARY
Bothreally.Theglycemicindex(GI)wasactuallydevelopedwithsignificantCanadianscientificcontributionthroughtheteamofDavidJenkinsetalatourownSt.Michael’sHospitalinToronto.Itwasdevelopedinrecog-nitionofobservationsthatsomehighly-favoureddiets,suchastheMediterraneandiet,doincorporatecarbo-hydrate(CHO),butthattheirCHOwerelesslikelytocausepost-prandialhyperglycemia,eveninpatientswithdiabetes.Onotherwords,somecarb’sare‘better’thanothers.
Theglycemicindexwasdevelopedtoquantify‘betterorworse’.ItisbasedonthepremisethatonesliceofwhitebreadhasaGIof1.Overthepastdecade,manycarb’shavebeenscoredrelativetoonesliceofwhitebread,producingaGIforeachone.Lowglycemicindexcarbohydratestendtoincludehighfibrecontent,suchaswholegrains.Theirslowerrateofdigestionresultsinmorelimitedanddelayedincreasesinbloodglucoselevels.
Themoreprocessedandrefinedacarbohydrate,generallythehighertheGI.Forexample,weconsideroatmealtobeahealthy,lowGIcarbanditis–aslongasit’spreparedinitstraditionalform:steelcutwholegrainsthatrequire45minutestocook.Popularprocessedoatmealpreparationsthatcanbecookedin5minutesormicro-wavedin1minute–haveaveryhighGIbecausethepre-cookingintheprocessingmethodhasdenaturedthecomplexCHO’s,leavingaproductnobetterthanwhitebread.
CookingmethodcanalsochangetheGIofafood.Forexample,slightlyundercookedpasta(aldente)hasalowerGIthanwell-cookedpasta.BakedpotatoesactuallyhavealowerGIthanmashed.RawvegetableshavealowerGIthancooked.
Finally,macronutrientcombinationscanalterafood’sGI.AddingfattendstodelayCHOdigestion,effectivelyraisingitsGI.Addingal-mondbuttertotoastisaneffectivewayofraisingitsGIandnutritivevalue.Inthepotatoeexampleabove,frenchfriesactuallyhavealowerGIthanmashedpotatoes.
Hereisasampleofatwodaylowglycemicindexdiet.
IthappenstobethatlowerGIdietfoods,orfoodcombinations,tendtoalsobemorefilling,makingthemappealingtopeoplewhoareactivelytryingtoreducetheirfoodportionsizeswhileavoidingexcessivehunger.RecentpopulardietbooksandTVshowshavereferencedtheGIconcept,andonedietisnamedafterit.Thisisonepopulardietphenomenonthatwecanactuallyendorse.
LowG.I.
HighG.I.
HighFibercerealsWholegrains
Lentils/Legumes
Mostfruit&vegetables,espwithskins,exceptmelons
MilkandyogurtPasta-cookedaldente
RefinedcerealsWhitebread
ShortgrainriceBakingpotatoes
SimpleSugars
The Glycemic Index – scientific tool or fad diet?
HIGH GI
1
LOW GI
TIME/HOURS
BLO
OD
GLU
COSE
LEV
ELS
The amount of carbohydrate in the reference and test food must be the same.
2
www.glycemicindex.com
s
August10,2011
DearColleagues
Type2Diabetesisarapidlygrowingepidemicinbothdevelopedanddevelopingnations.Itwillbeanin-creasingchallengetohealthcareprovidersastheCanadianpopulationages.InourAugustissueofClinicalPracticeUpdateDr.HarpreetBajajdiscussestheentityknownas“Pre-Diabetes”,exploringtheadditionofmetforminwhenlifestylemeasuresfailtoachievethedesiredgoalsofweightreductionandeuglycemia.MetforminiswellsupportedbycurrentevidencetodelayorpreventType2Diabetes.Glumetza,alongeractingformulationofmetformin,maybemoretoleratedbypatients,andasaonceadaydoseclaimbetteradherence.FromourownLMCpatientdatabase,aretrospectiveanalysisshowedatrendtowardlowerHbA1clevelsinpatientstakingGlumetzavsmeformin.
Alsointhisedition,TanyaLevin,aregistereddieticianatLMCBayview,givessomehelpfulinsightsontheLowGlycemicIndexDiet,whichwerecommendforourpre-diabeticanddiabeticpatients.
Sincerely,
Samantha SandlerMD,FRCPC
Editor,
ClinicalPracticeUpdate
C L I N I C A L P R A C T I C E U P D A T E I N
From the Endocrinology & Diabetes Specialists of the LMC Endocrinolgy Centres. The opinions expressed in this paper are those of the authors and do not necessarily reflect the opinions of LMC Endocrinology Centres or the editorial board of Clinical Practice Update.
EditorSamantha Sandler
MD, FRCPC
ONTARIOBARRIE
Suzan Abdel-Salam Diane Zatelny
BRAMPTONHarpreet Bajaj
ETOBICOKEHasnain Khandwala
Anila Seth-Sharma
MARKHAMSorin Beca
OAKVILLED. Y. Twum-Barima
THORNHILLJulie Daitchman
Meri GalterRonald Goldenberg
Gloria Rambaldini Robert Schlosser
Nina Wine
TORONTORonnie Aronson
Kimberly Mah-Poy Samantha Sandler
William Singer George Steiner
Adam Telner
QUEBECMONTRÉAL
Nouhad SalibaNahla Aris-Jilwan
MONTRÉALOUEST / WEST
Alex Skamene
ALBERTACALGARY
Munish KhoslaSue Pedersen
Stuart Ross